ParreÑo, Shella .

HRN: 28-45-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/03/2026
03/03/2026
IV
1g
Ptor
Stat CS
Checking Initial Appropriateness 
03/04/2026
MUPIROCIN 2%, 15G (TUBE)
03/04/2026
03/11/2026
TOPICAL
Pea Sized
OD
S/P Repeat CS
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: